EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

Solventless concentrates, especially rosin, are gaining popularity for their purity and flavor, reflecting a shift towards ...

Aurora said that is has discovered a novel source of genetic resistance against powdery mildew, which it has called PM2, that provides strong protection against the pathogen in cannabis sativa.

(RTTNews) - Aurora Cannabis Inc. (ACB.TO), a medical cannabis company based in Canada, Thursday has announced the discovery of a novel genetic resistance source against powdery mildew, known as PM2.

ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides ...

Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in ...